Cytosorbents (CTSO) Return on Invested Capital (2016 - 2025)

Cytosorbents (CTSO) has 10 years of Return on Invested Capital data on file, last reported at 0.01% in Q4 2025.

• For the quarter ending Q4 2025, Return on Invested Capital changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Dec 2025 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.02%, down 1.0% from the prior year.
• Return on Invested Capital for Q4 2025 stood at 0.01%, down from 0.01% in the prior quarter.
• Across five years, Return on Invested Capital topped out at 0.0% in Q1 2021 and bottomed at 0.02% in Q3 2024.
• The 5-year median for Return on Invested Capital is 0.01% (2022), against an average of 0.01%.
• The widest annual swing landed in 2022, when Return on Invested Capital slipped 1 bps; it then gained 2 bps in 2025.
• A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2021, then sank by 147 bps to 0.01% in 2022, then retreated by 12 bps to 0.01% in 2023, then plunged by 31 bps to 0.01% in 2024, then gained by 28 bps to 0.01% in 2025.
• The last three Return on Invested Capital figures came in at 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q1 2025), per Business Quant data.

Peer Comparison